D. E. Shaw & Co., Inc. Orgenesis Inc. Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.31 - $3.72 $231 - $372	-100 Reduced 0.4%	25,053 $87,000
Q4 2021 Feb 14, 2022	SELL	$2.61 - $4.9 $22,049 - $41,395	-8,448 Reduced 25.14%	25,153 $72,000
Q3 2021 Nov 15, 2021	BUY	$4.6 - $5.44 $154,564 - $182,789	33,601 New	33,601 $166,000

134K

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $28.1M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.